Pyruvate Dehydrogenase Deficiency clinical trials

Explore recruiting pyruvate dehydrogenase deficiency clinical trials.

Recruiting pyruvate dehydrogenase deficiency studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pyruvate Dehydrogenase Deficiency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PDH-RAVICTI - A PHASE II, MULTICENTRIC, PROSPECTIVE, NON-COMPARATIVE CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF THE TREATMENT OF PYRUVATE DEHYDROGENASE DEFICIENCY (PDH) PATIENTS WITH GLYCEROL PHENYLBUTYRATE (RAVICTI®)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Pyruvate Dehydrogenase Deficiency trials by city

Pyruvate Dehydrogenase Deficiency in Toronto Pyruvate Dehydrogenase Deficiency in Vancouver Pyruvate Dehydrogenase Deficiency in Montreal Pyruvate Dehydrogenase Deficiency in Calgary Pyruvate Dehydrogenase Deficiency in Edmonton Pyruvate Dehydrogenase Deficiency in Ottawa Pyruvate Dehydrogenase Deficiency in Winnipeg Pyruvate Dehydrogenase Deficiency in Quebec City Pyruvate Dehydrogenase Deficiency in Hamilton Pyruvate Dehydrogenase Deficiency in Kitchener Pyruvate Dehydrogenase Deficiency in London Pyruvate Dehydrogenase Deficiency in Halifax Pyruvate Dehydrogenase Deficiency in New York Pyruvate Dehydrogenase Deficiency in Los Angeles Pyruvate Dehydrogenase Deficiency in Chicago Pyruvate Dehydrogenase Deficiency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease